Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Xian-Peng Shi"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
PurposeTo evaluate the cost-effectiveness of sotorasib versus docetaxel in non-small cell lung cancer (NSCLC) patients with KRASG12C mutation from the China and United States’social perspective.Materials and MethodsA Markov model that included thre
Externí odkaz:
https://doaj.org/article/17d8b4cc6848400d96fb1f9ac5594568
Publikováno v:
Frontiers in Pharmacology; 2024, p1-11, 11p